WallStreetZenWallStreetZen

NYSE: ELV
Elevance Health Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Elevance Health earnings were $5.9B for the trailing 12 months ending Mar 31, 2025, with -3.2% growth year over year. The latest ELV earnings report on Mar 31, 2025 announced Q1 2025 earnings of $2.2B, up 422.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ELV reported annual earnings of $6.0B, with -0.1% growth. The next ELV earnings date is Jul 17, 2025.

ELV past earnings growth

How has ELV's earnings growth performed historically?

Company
-3.15%
Industry
24.34%
Market
34.13%
ELV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ELV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ELV's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ELV earnings history

Current Revenue
$183.3B
Current Earnings
$5.9B
Current Profit Margin
3.2%
ELV's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ELV Return on Equity

Current Company
13.9%
Current Industry
18.2%
Current Market
31.3%
ELV's Return on Equity (13.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ELV undefined

Current Company
5.1%
Current Industry
5.8%
ELV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ELV announces earnings.

ELV undefined

Current Company
11.73%
Current Industry
13.1%
ELV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELV vs Healthcare Plan Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELV$10.47B$5.92B+6.52%$25.80
CVS$9.11B$5.28B-5.39%$4.20
CI$10.66B$5.03B+6.65%$18.16
HUM$3.88B$1.71B-6.26%$14.18
CNC$6.47B$3.45B+27.57%$6.79
View Top Healthcare Plan Stocks

ELV earnings dates

Next earnings date
Jul 17, 2025

Elevance Health Earnings Reports & History FAQ

What were Elevance Health's earnings last quarter?

On ELV's earnings call on Invalid Date, Elevance Health (NYSE: ELV) reported Q1 2025 earnings per share (EPS) of $9.64, up 0.1% year over year. Total ELV earnings for the quarter were $2.18 billion. In the same quarter last year, Elevance Health's earnings per share (EPS) was $9.65.

If you're new to stock investing, here's how to buy Elevance Health stock.

When does Elevance Health report earnings?

The next ELV earnings call is Invalid Date. Add ELV to your watchlist to be reminded of Elevance Health's next earnings date.

Is Elevance Health profitable or losing money?

As of the last Elevance Health earnings report, Elevance Health is currently profitable. Elevance Health's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $5.92 billion, a 5.24% decrease year over year.

What was ELV's earnings growth in the past year?

As of Elevance Health's earnings date in Invalid Date, Elevance Health's earnings has grown -3.15% year over year. This is 27.49 percentage points lower than the US Healthcare Plans industry earnings growth rate of 24.34%. ELV earnings in the past year totalled $5.92 billion.

What are Elevance Health's earnings expectations?

The current EPS estimate for Elevance Health's earnings report in Invalid Date is $9.19.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.